Big Move In Solana: 2 Reasons Why This Top Token Surged 7% Off Yesterday's Bottom
Summarize this article with:
By Chris MacDonald – Dec 19, 2025 at 12:12PM ESTKey PointsA broader market rebound today across a number of speculative risk assets is taking Solana and its peers higher.However, there are two key Solana-specific tailwinds I think investors should be paying attention to as longer-term bullish catalysts. Here's what investors should be watching with the world's seventh-largest digital asset today. These 10 Stocks Could Mint the Next Wave of Millionaires ›CRYPTO: SOLSolanaMarket Cap$70BToday's Changeangle-down(0.87%) $1.07Current Price$123.92Price as of December 19, 2025 at 1:04 PM ETSolana is among the biggest gainers in today's market among top-10 cryptocurrencies.Given the relatively steady declines that have proliferated in the cryptocurrency sector over the past week, today's price action is certainly welcome to see. Many top tokens, including Solana (SOL +0.87%), have rallied nicely off yesterday's lows. As of 11:00 a.m. ET, Solana has surged 7.1% from 4:00 p.m. ET yesterday, signaling investors are looking for tokens with considerable upside potential when buying this dip. ExpandCRYPTO: SOLSolanaToday's Change(0.87%) $1.07Current Price$123.92Key Data PointsMarket Cap$70BDay's Range$117.62 - $126.5152wk Range$96.70 - $293.31Volume6.9B I continue to think that Solana is among the top mega-cap digital assets worth considering as a long-term hold. However, over short-term periods, investor sentiment can swing sharply, allowing investors to benefit from near-term dips as buying opportunities. And while some of today's price action in Solana and other top tokens can be attributed to an improving macro backdrop (with other risk assets rising as well today), there are some token-specific catalysts I think are worth considering as key drivers of today's move in this top-tier layer-1 project. What's driving Solana's move today? Source: Getty Images. One of the more compelling reports I've seen circulating this morning revolves around a push from the Solana Foundation to evaluate whether its network can withstand a potential attack from hackers using quantum computing technology. Partnering with Project Eleven, a post-quantum security firm, the Solana team has now deployed a quantum-resistant testnet following a comprehensive threat assessment. This move could pave the way for other projects to follow suit. Still, in the meantime, those in the crypto space concerned about hacks and breaches potentially stemming from quantum computing technology may find safe harbor with Solana, which utilizes new cryptography to guard against future security concerns. The other notable catalyst driving upside in Solana today appears to be related to yet another non-crypto company transitioning into a digital assets treasury company. Mangoceuticals (MGRX 46.28%) announced plans this morning to focus on acquiring and holding Solana in its new subsidiary, with purchases starting at $100 million.Advertisement This move validates Solana as a treasury-worthy asset and is intriguing in that I can certainly envision a future in which other corporate entities follow suit. Read NextDec 19, 2025 •By Dominic BasultoXRP vs. Solana: Which Is More Likely to Be a Millionaire-Maker?Dec 15, 2025 •By Chris MacDonald5 Reasons Why Today's 3% Drop in Solana Doesn't Make SenseDec 15, 2025 •By Emma NewberyThe Case for Buying Solana Before the Alpenglow UpgradeDec 11, 2025 •By Chris MacDonaldHere's What Drove a Seriously Topsy-Turvy Day in SolanaDec 5, 2025 •By Dominic BasultoThe Cryptocurrency That Could Be About to Explode 1,000%Dec 2, 2025 •By Bram BerkowitzWhy Solana Is Surging TodayAbout the AuthorChris MacDonald is a contributing Motley Fool cryptocurrency analyst covering digital assets and blockchain companies. Chris has more than 10 years of professional experience in venture capital and corporate finance. He holds an MBA in finance from the University of British Columbia’s Sauder School of Business.TMFChrisMacDStocks MentionedSolanaCRYPTO: SOL$123.92 (+0.01%) $+1.07MangoceuticalsNASDAQ: MGRX$0.70 (0.46%) $0.61*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.Advertisement